Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK

Br J Haematol. 2020 May;189(3):e79-e81. doi: 10.1111/bjh.16485. Epub 2020 Feb 3.

Authors

Natalia Curto-Garcia¹, Andrew J Doyle¹, Karen A Breen¹, Donal P McLornan¹, Deepti H Radia¹, Beverley J Hunt¹, Gavin Ling¹, Claire N Harrison¹

Affiliation

¹ Department of Haematology, Guy's & St Thomas' NHS Foundation Trust, London, UK.

PMID: 32011726
DOI: 10.1111/bjh.16485

No abstract available

Keywords: direct oral anticoagulant therapy; myeloproliferative disorder; thrombosis (venous).

Publication types

Letter

MeSH terms

Administration, Oral
Adult
Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Female
Humans
Male
Middle Aged
Myeloproliferative Disorders / drug therapy*
Neoplasms / drug therapy*
Tertiary Care Centers
Treatment Outcome
United Kingdom
Young Adult

Substances

Anticoagulants